AI supported prediction and analysis of the pharmacophores for biologically active compounds design


The use of artificial intelligence (AI) in the area of medical diagnostics and medical devices.

The service consists of designing a set of pharmacophores, enabling the selection of biologically active compounds targeting a specific molecular target from databases. Proprietary software is used to design the pharmacophores, allowing prediction of receptor binding sites based on molecular dynamics simulations in a cosolvent environment and artificial intelligence-based solutions that optimise the spatial distribution of pharmacophore-defining features.

Service delivery phases

Contact us for more details.


Contact us for more details.